183 related articles for article (PubMed ID: 9157855)
1. The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles.
Laniado M; Grönewäller E; Kopp AF; Kaminsky SF; Hamm B; Jacobsen TF; Claussen CD
Abdom Imaging; 1997; 22(4):381-8. PubMed ID: 9157855
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging.
Grubnic S; Padhani AR; Revell PB; Husband JE
AJR Am J Roentgenol; 1999 Jul; 173(1):173-8. PubMed ID: 10397122
[TBL] [Abstract][Full Text] [Related]
3. The value of hyoscine butylbromide in pelvic MRI.
Johnson W; Taylor MB; Carrington BM; Bonington SC; Swindell R
Clin Radiol; 2007 Nov; 62(11):1087-93. PubMed ID: 17920868
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of oral magnetic particles in MRI of abdomen and pelvis.
MacVicar D; Jacobsen TF; Guy R; Husband JE
Clin Radiol; 1993 Mar; 47(3):183-8. PubMed ID: 8472481
[TBL] [Abstract][Full Text] [Related]
5. Contribution of oral magnetic particles in MR imaging of the abdomen with spin-echo and gradient-echo sequences.
Boudghène FP; Bach-Gansmo T; Grange JD; Lame S; Nantois C; Wallays C; Bigot JM
J Magn Reson Imaging; 1993; 3(1):107-12. PubMed ID: 8428075
[TBL] [Abstract][Full Text] [Related]
6. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
Tytgat GN
Drugs; 2007; 67(9):1343-57. PubMed ID: 17547475
[TBL] [Abstract][Full Text] [Related]
7. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.
Ullrich T; Quentin M; Schmaltz AK; Arsov C; Rubbert C; Blondin D; Rabenalt R; Albers P; Antoch G; Schimmöller L
Eur Radiol; 2018 Jan; 28(1):17-23. PubMed ID: 28687912
[TBL] [Abstract][Full Text] [Related]
8. High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality.
Wagner M; Klessen C; Rief M; Elgeti T; Taupitz M; Hamm B; Asbach P
Acta Radiol; 2008 May; 49(4):376-82. PubMed ID: 18415778
[TBL] [Abstract][Full Text] [Related]
9. Abdominal MRI using a negative contrast agent.
Bach-Gansmo T; Dupas B; Gayet-Delacroix M; Lambrechts M
Br J Radiol; 1993 May; 66(785):420-5. PubMed ID: 8319063
[TBL] [Abstract][Full Text] [Related]
10. Oral magnetic particles. Results from clinical phase II trials in 216 patients.
Oksendal AN; Bach-Gansmo T; Jacobsen TF; Eide H; Andrew E
Acta Radiol; 1993 Mar; 34(2):187-93. PubMed ID: 8452728
[TBL] [Abstract][Full Text] [Related]
11. Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations.
Dosdá R; Martí-Bonmatí L; Ronchera-Oms CL; Mollá E; Arana E
Eur Radiol; 2003 Feb; 13(2):294-8. PubMed ID: 12598993
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
[TBL] [Abstract][Full Text] [Related]
13. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs.
Martí-Bonmatí L; Graells M; Ronchera-Oms CL
Abdom Imaging; 1996; 21(4):309-13. PubMed ID: 8661572
[TBL] [Abstract][Full Text] [Related]
14. Colonic distention at CT colonography: randomized evaluation of both IV hyoscine butylbromide and automated carbon dioxide insufflation.
Nagata K; Fujiwara M; Shimamoto T; Iida N; Mogi T; Mitsushima T
AJR Am J Roentgenol; 2015 Jan; 204(1):76-82. PubMed ID: 25539240
[TBL] [Abstract][Full Text] [Related]
15. Emergency department management of undifferentiated abdominal pain with hyoscine butylbromide and paracetamol: a randomised control trial.
Remington-Hobbs J; Petts G; Harris T
Emerg Med J; 2012 Dec; 29(12):989-94. PubMed ID: 22307926
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of two oral hyoscine butylbromide formulations in Chinese patients with recurrent episodes of self-reported gastric or intestinal spasm-like pain.
Ge Z; Yuan Y; Zhang S; Hou X; Wang J; Cai J; Shi R; Li Y; Wang B; Ji F; Richter E; Schaefer E
Int J Clin Pharmacol Ther; 2011 Mar; 49(3):198-205. PubMed ID: 21329622
[TBL] [Abstract][Full Text] [Related]
17. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
[TBL] [Abstract][Full Text] [Related]
18. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
19. Oral magnetic particles in MR imaging of the abdomen and pelvis.
Rinck PA; Smevik O; Nilsen G; Klepp O; Onsrud M; Oksendal A; Børseth A
Radiology; 1991 Mar; 178(3):775-9. PubMed ID: 1994417
[TBL] [Abstract][Full Text] [Related]
20. The role of routinely given hyoscine-N-butylbromide in colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial.
Ristikankare M; Karinen-Mantila H
Scand J Gastroenterol; 2016 Mar; 51(3):368-73. PubMed ID: 26554619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
